Document Detail


Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled study.
MedLine Citation:
PMID:  81655     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
By multiple criteria, inosiplex-a reputed stimulator of virus-sensitized lymphocytes-had no demonstrable therapeutic effects in a preliminary controlled study of patients with localized herpes zoster and cancer. Lymphocytes from the six drug-treated patients were no more responsive to varicella-zoster antigen and phytohemagglutinin than were lymphocytes from seven patients who received a placebo.
Authors:
S Feldman; F A Hayes; S Chaudhary; M Ossi
Related Documents :
9580175 - The production of mlr-blocking factors after lymphocyte immunotherapy for rsa does not ...
6226835 - Interstitial lung disease. assessment by bronchoalveolar lavage.
2539255 - Properties of glucocorticoid receptors in epstein-barr virus-transformed lymphocytes fr...
2261345 - Correlation of chromosome abnormalities with laboratory features and clinical course in...
887965 - Angiographic findings in giant cell arteritis.
25279875 - Screening for connective tissue disease in pulmonary arterial hypertension.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  14     ISSN:  0066-4804     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  1978 Sep 
Date Detail:
Created Date:  1978-12-27     Completed Date:  1978-12-27     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  495-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Clinical Trials as Topic
Double-Blind Method
Herpes Zoster / complications,  drug therapy*
Humans
Immunity, Cellular / drug effects
Inosine / analogs & derivatives*
Inosine Pranobex / pharmacology,  therapeutic use*
Neoplasms / complications
Placebos
Chemical
Reg. No./Substance:
0/Placebos; 36703-88-5/Inosine Pranobex; 58-63-9/Inosine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differential spectrophotometric method of analysing levorin in the culture broth and in the mycelium
Next Document:  Nursing care of the infant in surgery.